Electromedical Technologies, Inc.
EMED · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | -0.02 |
| FCF Yield | -43.29% | -593.48% | -86.40% | -34.94% |
| EV / EBITDA | -1.80 | -1.09 | -0.94 | -0.90 |
| Quality | ||||
| ROIC | 47.08% | 177.12% | 684.75% | -442.40% |
| Gross Margin | 64.79% | 77.51% | 77.28% | 78.04% |
| Cash Conversion Ratio | 0.09 | 0.54 | 0.22 | 0.14 |
| Growth | ||||
| Revenue 3-Year CAGR | -20.02% | 14.13% | 15.93% | 3.03% |
| Free Cash Flow Growth | 92.83% | -102.64% | 35.21% | 10.70% |
| Safety | ||||
| Net Debt / EBITDA | -1.54 | -0.94 | -0.61 | -0.23 |
| Interest Coverage | -4.62 | -2.31 | -2.03 | -1.15 |
| Efficiency | ||||
| Inventory Turnover | 9.97 | 4.43 | 4.21 | 0.91 |
| Cash Conversion Cycle | -482.42 | -204.55 | -283.02 | 20.94 |